Explore the words cloud of the iReceptor Plus project. It provides you a very rough idea of what is the project "iReceptor Plus" about.
The following table provides information about the project.
BAR ILAN UNIVERSITY
|Coordinator Country||Israel [IL]|
|Total cost||8˙505˙675 €|
|EC max contribution||7˙856˙925 € (92%)|
1. H2020-EU.3.1.5. (Methods and data)
|Duration (year-month-day)||from 2019-01-01 to 2022-12-31|
Take a look of project's partnership.
|1||BAR ILAN UNIVERSITY||IL (RAMAT GAN)||coordinator||975˙750.00|
|2||INESC TEC - INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES, TECNOLOGIA E CIENCIA||PT (PORTO)||participant||877˙292.00|
|3||THE UNIVERSITY OF TEXAS SYSTEM||US (AUSTIN)||participant||679˙800.00|
|4||DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG||DE (HEIDELBERG)||participant||649˙750.00|
|5||SORBONNE UNIVERSITE||FR (PARIS)||participant||647˙000.00|
|6||ASSISTANCE PUBLIQUE HOPITAUX DE PARIS||FR (PARIS)||participant||556˙875.00|
|7||ASCORA GMBH||DE (GANDERKESEE)||participant||508˙750.00|
|8||UNIVERSITY OF HAIFA||IL (HAIFA)||participant||499˙375.00|
|9||INTERTEAM LTD||IL (JERUSALEM)||participant||400˙707.00|
|10||INFINIDAT LTD||IL (HERZILIYA)||participant||386˙750.00|
|11||UNIVERSITETET I OSLO||NO (OSLO)||participant||360˙000.00|
|12||MITMYNID LDA||PT (AMARANTE)||participant||301˙250.00|
|13||ACONDICIONAMIENTO TARRASENSE ASSOCIACION||ES (TERRASSA)||participant||280˙625.00|
|15||CLALIT HEALTH SERVICES||IL (TEL AVIV)||participant||167˙500.00|
|16||10X GENOMICS, INC.||US (PLEASANTON)||participant||150˙250.00|
|17||MEDGENOME INC||US (FOSTER CITY)||participant||150˙250.00|
|18||OSLO UNIVERSITETSSYKEHUS HF||NO (OSLO)||participant||0.00|
|19||Simon Fraser University||CA (BURNABY)||participant||0.00|
|20||THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO||CA (TORONTO)||participant||0.00|
Background: Many cutting-edge therapies rely on manipulating the adaptive immune system, which has evolved a vast diversity (repertoire) of immune receptors to recognize and remove pathogens and cancer cells. The sequence-data sets characterizing this Adaptive Immune Receptor Repertoire (i.e., AIRR-seq data) have the potential to revolutionize vaccine research and the development of therapies against autoimmune diseases and cancer; however, AIRR-seq data are typically stored and curated by individual labs, using a variety of tools and technologies. Sharing these data in a common way across disease studies, labs, and institutions around the world will improve our ability to recognize patterns in basic research and clinical trials, and increase our confidence in these patterns. The existing iReceptor Platform uses community-developed standards to facilitate sharing of AIRR-seq data by enabling queries across a system of distributed data repositories.
Project: The iReceptor Plus consortium of researchers from Europe and Canada will address several key challenges to optimally sharing AIRR-seq data among public and industrial partners: protecting patient privacy and the intellectual property of partners, performing complex analyses on data brought together from many sources, and expanding the size and number of repositories that can be integrated in the network.
Impact: The iReceptor Plus project will facilitate sharing of AIRR-seq data among multiple institutions, including biopharmaceutical companies and researchers working with human confidential data, across multiple diseases, treatments and populations. This will lead to a better understanding of the causes of infectious and autoimmune diseases and cancer, which can lead to early detection and suggest novel therapies. These improvements will reduce the social and economic burden of these diseases, advance Europe and Canada’s leadership role in immunotherapy, and contribute to improved patient care worldwide
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IRECEPTOR PLUS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IRECEPTOR PLUS" are provided by the European Opendata Portal: CORDIS opendata.
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.Read More
Common Infrastructure for National Cohorts in Europe, Canada, and AfricaRead More
ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPYRead More